J.H.M. Schellens
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 4
- PARP inhibition in cancer therapy 3
- Neutropenia and Cancer Infections 3
-
- Cancer therapeutics and mechanisms 3
- DNA Repair Mechanisms 2
- Co-authors
- Hilde Rosing (8 shared papers)Jos H. Beijnen (9 shared papers)Olaf van Tellingen (2 shared papers)J. H. Beijnen (1 shared paper)W W ten Bokkel Huinink (1 shared paper)Kenneth R. Brouwer (1 shared paper)W J Nooijen (1 shared paper)Heleen A. Bardelmeijer (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Investigational New Drugs (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
J.H.M. Schellens
15 papers receiving 511 citations
Peers
Comparison fields: 5 of 74
- Oncology 378
- Pharmacology 86
- Reproductive Medicine 68
- Pharmaceutical Science 37
- Pediatrics, Perinatology and Child Health 118
Countries citing papers authored by J.H.M. Schellens
This map shows the geographic impact of J.H.M. Schellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H.M. Schellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H.M. Schellens more than expected).
Fields of papers citing papers by J.H.M. Schellens
This network shows the impact of papers produced by J.H.M. Schellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H.M. Schellens. The network helps show where J.H.M. Schellens may publish in the future.
Co-authors
The 25 scholars most cited alongside J.H.M. Schellens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. | 1999 | 163 |
| 2 | Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. | 2000 | 103 |
| 3 | 2008 | 65 | |
| 4 | 2007 | 49 | |
| 5 | 2020 | 35 | |
| 6 | 2006 | 29 | |
| 7 | 2004 | 20 | |
| 8 | 2014 | 18 | |
| 9 | 2016 | 16 | |
| 10 | 2017 | 16 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 3 | |
| 13 | 2016 | 3 | |
| 14 | 2017 | 3 | |
| 15 | 2001 | 1 |
About J.H.M. Schellens
J.H.M. Schellens is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Toxicology, having authored 15 papers that have together received 528 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers), Neutropenia and Cancer Infections (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (378 citations), Pharmacology (86 citations), Reproductive Medicine (68 citations), Pharmaceutical Science (37 citations) and Pediatrics, Perinatology and Child Health (118 citations). J.H.M. Schellens has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Hilde Rosing, Jos H. Beijnen, Olaf van Tellingen, J. H. Beijnen, W W ten Bokkel Huinink, Kenneth R. Brouwer, W J Nooijen, Heleen A. Bardelmeijer, Johann S. de Bono and Peter C.C. Fong. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmaceutical and Biomedical Analysis, Investigational New Drugs, Clinical Pharmacology & Therapeutics and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.